Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells.

Traditional chemotherapies, aimed at DNA replication in rapidly dividing cells, have achieved only limited success in the treatment of carcinomas due largely to their lack of specificity for cells of tumorigenic origin. It is important, therefore, to investigate treatment strategies aimed at novel cellular targets that are sufficiently different between normal cells and cancer cells so as to provide a basis for selective tumor cell killing. Delocalized lipophilic cations (DLCs) are concentrated by cells and into mitochondria in response to negative inside transmembrane potentials. The higher plasma and/or mitochondrial membrane potentials of carcinoma cells compared to normal epithelial cells account for the selective accumulation of DLCs in carcinoma mitochondria. Since most DLCs are toxic to mitochondria at high concentrations, their selective accumulation in carcinoma mitochondria and consequent mitochondrial toxicity provide a basis for selective carcinoma cell killing. Several of these compounds have already displayed some degree of efficacy as chemotherapeutic agents in vitro and in vivo. The effectiveness of DLCs can also be enhanced by their use in photochemotherapy or combination drug therapy. Discovery of the biochemical differences that account for the higher membrane potentials in carcinoma cells is expected to lead to the design of new DLCs targeted specifically to those differences, resulting in even greater selectivity and efficacy for tumor cell killing.

[1]  John Calvin Reed.  Bcl-2 and the regulation of programmed cell death , 1994, The Journal of cell biology.

[2]  T. Delaney,et al.  Photodynamic therapy of cancer. , 1988, Comprehensive therapy.

[3]  A. S. Sun,et al.  Oxidoreductase activities in normal rat liver, tumor-bearing rat liver, and hepatoma HC-252. , 1980, Cancer research.

[4]  Guido Kroemer,et al.  The proto-oncogene Bcl-2 and its role in regulating apoptosis , 1997, Nature Medicine.

[5]  S. Papa,et al.  Oxidative Phosphorylation Enzymes in Normal and Neoplastic Cell Growth , 1997, Journal of bioenergetics and biomembranes.

[6]  I. Summerhayes,et al.  Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. K. Powers,et al.  THE EFFECT OF A CHALCOGENAPYRYLIUM DYE WITH AND WITHOUT PHOTOLYSIS ON MITOCHONDRIAL FUNCTION IN NORMAL AND TUMOR CELLS , 1989, Photochemistry and photobiology.

[8]  L. Augenlicht,et al.  Expression of mitochondrial cytochrome c oxidase in human colonic cell differentiation, transformation, and risk for colonic cancer. , 1990, Cancer research.

[9]  J. Wood,et al.  Cytotoxic effect of thiacarbocyanine dyes on human colon carcinoma cells and inhibition of bovine heart mitochondrial NADH-ubiquinone reductase activity via a rotenone-type mechanism by two of the dyes. , 1993, Biochemical pharmacology.

[10]  M L Walsh,et al.  Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy , 1981, The Journal of cell biology.

[11]  M. Baraldi,et al.  Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. , 1998, Life sciences.

[12]  G. Kroemer,et al.  Mitochondrion as a novel target of anticancer chemotherapy. , 2000, Journal of the National Cancer Institute.

[13]  J. Modica-Napolitano,et al.  Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077. , 1996, Cancer research.

[14]  L. B. Chen,et al.  AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity. , 1994, Cancer research.

[15]  L. Scorrano,et al.  The mitochondrial permeability transition , 2022, BioFactors.

[16]  S. Goldfarb,et al.  Comparison of the adenine nucleotide translocase in hepatomas and rat liver mitochondria. , 1979, Biochimica et biophysica acta.

[17]  J C Reed,et al.  Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype , 1997, Science.

[18]  J. Lemasters,et al.  Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: spectral and metabolic properties. , 1986, Biochimica et biophysica acta.

[19]  A. Oseroff,et al.  Mechanisms of mitochondrial photosensitization by the cationic dye, N,N-bis(2-ethyl-1,3-dioxylene)kryptocyanine (EDKC): preferential inactivation of complex I in the electron transport chain. , 1987, Cancer research.

[20]  Š. Kǔzela,et al.  Increased steady-state levels of several mitochondrial and nuclear gene transcripts in rat hepatoma with a low content of mitochondria. , 1992, European journal of biochemistry.

[21]  A. Oseroff,et al.  Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  I. Summerhayes,et al.  Selective toxicity of rhodamine 123 in carcinoma cells in vitro. , 1983, Cancer research.

[23]  J. Modica-Napolitano,et al.  In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function. , 1996, Cancer research.

[24]  M L Yarmush,et al.  STRATEGIES FOR SELECTIVE CANCER PHOTOCHEMOTHERAPY: ANTIBODY‐TARGETED and SELECTIVE CARCINOMA CELL PHOTOLYSIS * , 1987, Photochemistry and photobiology.

[25]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[26]  T. Lampidis,et al.  Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. , 1985, The Journal of biological chemistry.

[27]  J. Modica-Napolitano,et al.  Basis for the selective cytotoxicity of rhodamine 123. , 1987, Cancer research.

[28]  R. Barbour,et al.  Adenine nucleotide transport in hepatoma mitochondria. Characterization of factors influencing the kinetics of ADP and ATP uptake. , 1983, Biochimica et biophysica acta.

[29]  V. Skulachev,et al.  Mechanism of Coupling of Oxidative Phosphorylation and the Membrane Potential of Mitochondria , 1969, Nature.

[30]  Smiley St,et al.  Inhibition of bovine heart mitochondrial and Paracoccus denitrificans NADH----ubiquinone reductase by dequalinium chloride and three structurally related quinolinium compounds. , 1989 .

[31]  D. Bigner,et al.  Differential retention of rhodamine 123 by avian sarcoma virus‐induced glioma and normal brain tissue of the rat in vivo , 1987, Cancer.

[32]  John Calvin Reed.  Double identity for proteins of the Bcl-2 family , 1997, Nature.

[33]  K. Sepkowitz,et al.  A study of some mitochondrial and peroxisomal enzymes in human colonic adenocarcinoma. , 1981, Laboratory investigation; a journal of technical methods and pathology.

[34]  R. Salem,et al.  Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Shishido,et al.  MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. , 1996, Cancer research.

[36]  P. Pedersen,et al.  Uncoupler-stimulated adenosine triphosphatase activity. Deficiency in intact mitochondria from Morris hepatomas and ascites tumor cells. , 1974, The Journal of biological chemistry.

[37]  A. Koretsky,et al.  The role of creatine kinase in inhibition of mitochondrial permeability transition , 1997, FEBS letters.

[38]  L. Cerullo.  Application Of Lasers In Neurosurgery , 1988 .

[39]  M. Wésolowski-Louvel,et al.  Expression of human ANT2 gene in highly proliferative cells: GRBOX, a new transcriptional element, is involved in the regulation of glycolytic ATP import into mitochondria. , 1998, Journal of molecular biology.

[40]  J. Modica-Napolitano,et al.  Rhodamine 123 inhibits bioenergetic function in isolated rat liver mitochondria. , 1984, Biochemical and biophysical research communications.

[41]  S. Galiègue,et al.  Cloning and Characterization of PRAX-1 , 1999, The Journal of Biological Chemistry.

[42]  D. Rideout,et al.  Mechanism of inhibition of fadu hypopharyngeal carcinoma cell growth by tetraphenylphosphonium chloride , 1994, International journal of cancer.

[43]  A. Heddi,et al.  Expression of oxidative phosphorylation genes in renal tumors and tumoral cell lines , 1996, Molecular carcinogenesis.

[44]  J. Mangion,et al.  BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability , 1998, Oncogene.

[45]  A. Oseroff,et al.  Mitochondrial toxicity of cationic photosensitizers for photochemotherapy. , 1990, Cancer research.

[46]  T. Lampidis,et al.  Anticarcinoma activity in vivo of rhodamine 123, a mitochondrial-specific dye. , 1983, Science.

[47]  M L Walsh,et al.  Localization of mitochondria in living cells with rhodamine 123. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[48]  I. Summerhayes,et al.  Rhodamine-123 selectively reduces clonal growth of carcinoma cells in vitro. , 1982, Science.

[49]  S. Tommasi,et al.  OXIDATIVE PHOSPHORYLATION AND F0F1 ATP SYNTHASE ACTIVITY OF HUMAN HEPATOCELLULAR CARCINOMA , 1996 .

[50]  L. B. Chen,et al.  Mitochondrial membrane potential in living cells. , 1988, Annual review of cell biology.

[51]  J. Modica-Napolitano,et al.  Photoactivation enhances the mitochondrial toxicity of the cationic rhodacyanine MKT-077. , 1998, Cancer research.

[52]  G. Woldegiorgis,et al.  Adenine nucleotide translocase activity and sensitivity to inhibitors in hepatomas. Comparison of the ADP/ATP carrier in mitochondria and in a purified reconstituted liposome system. , 1985, The Journal of biological chemistry.

[53]  K. Wadwa,et al.  Cationic Triarylmethane Photosensitizers For Selective Photochemotherapy: Victoria Blue-Bo, Victoria Blue-R And Malachite Green , 1989, Other Conferences.

[54]  J. M. Izquierdo,et al.  Mitochondrial Biogenesis in the Liver during Development and Oncogenesis , 1997, Journal of bioenergetics and biomembranes.

[55]  A. Halestrap,et al.  Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. , 1990, The Biochemical journal.

[56]  G. Gillespie,et al.  Laser photochemotherapy of rhodamine-123 sensitized human glioma cells in vitro. , 1986, Journal of neurosurgery.